GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 81298810131

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81298810131 and manufactured by TOSOH BIOSCIENCE, INC.. The registration is held by MD CONSULTORIA E COMERCIO DE PRODUTOS PARA LABORATORIO LTDA - ME with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81298810131
Registration Details
ANVISA Registration Number: 81298810131
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Hemoglobin A1c Controls - Levels 1 and 2 (Controles para Hemoglobina A1c - Níveis 1 e 2)
Risk Class II

Registration Details

81298810131

25351382005202042

23000972000181

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Dec 30, 2020

VIGENTE

09/18/2025 19:00:01